Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision tag was updated from v3.6.3 to v3.6.4. This appears to be a minor software update with no evident changes to content or user-facing features in the provided context.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's update dates were refreshed in July 2026, replacing earlier January 2026 timestamps. This reflects routine maintenance to keep the study record's metadata current.
    Difference
    0.2%
    Check dated 2026-07-20T02:13:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new build of the page content without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-07-05T14:34:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new publication citation by Derbala et al. was added to the study's Publications, documenting AI-guided analysis predicting pembrolizumab response in rare tumors. The page revision was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-28T08:47:03.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'), reflecting a change in participant availability. Updated the Interventions label from 'Intervention / Treatment' to 'Intervention/Treatment' and added a new revision (Revision: v3.6.0) while removing the older label (Revision: v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-14T05:41:16.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.5, replacing the previous v3.5.4, reflecting a minor metadata update.
    Difference
    0.0%
    Check dated 2026-06-07T01:51:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.